Fundamentals

Valuation

Metric	Q1	Q2	Δ in %
EV/EBITDA	-5.30	115.33	121.77
Graham Fair Price	22.70	124.26	101.27
PEG	-20.06	1.29	-1.61
Price/Book	8.94	8.71	7.99
Price/Cash Flow	14.41	136.98	119.73
Prices/Earnings	-32.26	71.82	106.02
Price/Sales	3.87	48.79	46.98
Price/FCF	14.41	136.98	119.73
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q1	Q2	Δ in %
Gross Profit Margin	0.48	0.56	0.56
Operating Margin	13.44	0.27	0.23
ROA	62.50	0.01	< 0.005
ROE	0.02	0.03	60.81
ROIC	0.02	0.02	33.97
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q2	Δ in %
Debt QOQ	-0.02	0.93	-97.34
Dividends QOQ	0.17	-0.02	-85.31
EBIT QOQ	-0.34	0.18	-45.93
EPS QOQ	-0.66	0.56	-15.26
FCF QOQ	< 0.005	-0.05	-721.89
Revenue QOQ	0.29	0.04	-84.67
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q1	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	32.69	30.22	-7.54
Days Sales Outstanding (DSO)	37.39	39.64	6.02
Inventory Turnover	2.75	2.98	8.16
Debt/Capitalization	0.52	0.51	-0.98
Quick Ratio	0.83	0.76	-8.16
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q1	Q2	Δ in %
Book Value	155.50	150.45	-3.24
Cash	26.25	21.09	-19.63
Capex	-0.27	-0.28	-5.17
Free Cash Flow	10.38	9.57	-7.87
Revenue	26.46	26.85	1.48
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q1	Q2	Δ in %
Current Ratio	1.33	1.25	-6.04
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	12.46	10.99	-11.75
Naive Interpretation	Member

06 - Financial Health · Weak

Rating